Iron Deficiency in Hemodialysis Patients – Evaluation of a Combined Treatment with Iron Sucrose and Erythropoietin-Alpha: Predictors of Response, Efficacy and Safety
None
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2012
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/37589 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Iron Deficiency in Hemodialysis Patients – Evaluation of a Combined Treatment with Iron Sucrose and Erythropoietin-Alpha: Predictors of Response, Efficacy and Safety
- Iron Deficiency and Hypothyroidism
- rhEPO for the Treatment of Erythropoietin Resistant Anemia in Hemodialysis Patients – Risks and Benefits
- Current Anemia Treatment in Hemodialysis Patients: The Challenge for Secure Use of Erythropoietin-Stimulating Agents
- Introductory Chapter: Anaemia and Iron Deficiency in Heart Failure
- Potential Marker for Diagnosis and Screening of Iron Deficiency Anemia in Children
- Natural Iron Chelators as Potential Therapeutic Agents for the Treatment of Iron Overload Diseases